April 11 (Reuters) - Valeant Pharmaceuticals (NYSE:VRX) International
Inc VRX.TO
* Entered into amendment and waiver to third
amended,restated credit,guaranty agreement, dated as of feb 13,
2012
* Amendment extends deadline for filing company's form 10-k
for fiscal year ended dec. 31, 2015 to may 31, 2016
* Amendment also permits company to incur up to $750 million
of additional unsecured indebtedness at any time
* Amendment modifies add-backs to consolidated adjusted
ebitda under credit agreement
Source text for Eikon:
Further company coverage: VRX.TO
(Bengaluru Newsroom: +1-646-223-8780)